Today: 10 June 2026
Browse Category

NASDAQ:CMBM 29 October 2025 - 12 November 2025

Cambium Networks Stock Jumps on Starlink News as Delisting Looms – Analysts See 385% Upside

Cambium Networks (NASDAQ: CMBM) Pops on Nov. 12 as Traders Position for Thursday’s Results and Starlink Momentum

Cambium Networks (CMBM) shares surged about 15% intraday to $2.60, with market cap near $63.5 million, amid a tech rally and ahead of Q2 FY2025 results due Nov. 13. The stock remains volatile following an Oct. 29 Starlink integration announcement. Nasdaq has flagged CMBM for possible delisting over bid price and filing issues; a hearing is pending.
12 November 2025
···
Cambium Networks (CMBM) Stock Soars 377% on Starlink Tie-Up — Delisting Threats Loom

Cambium Networks (CMBM) Stock Soars 377% on Starlink Tie-Up — Delisting Threats Loom

Cambium Networks shares soared 377% to $2.95 on Oct 29 after announcing integration of its ONE Network platform with SpaceX’s Starlink. After-hours trading pushed the stock as high as $6.69. The rally followed recent Nasdaq delisting warnings and a CFO departure. Cambium’s market cap reached about $83 million, with analysts split on the outlook amid ongoing losses and volatile trading.
30 October 2025
··
Cambium Networks Stock Jumps on Starlink News as Delisting Looms – Analysts See 385% Upside

Cambium Networks Stock Jumps on Starlink News as Delisting Looms – Analysts See 385% Upside

Cambium Networks traded at $0.62 on Oct. 29, 2025, down 88% in a year, with a $17.5 million market cap and facing Nasdaq delisting after six months under $1. The company announced Starlink integration and new Wi-Fi 7 radios this month. Revenue fell 35% year-over-year; Q3 results are due Nov. 6. CFO Jacob Sayer exited in September amid missed SEC deadlines and ongoing losses.
29 October 2025
·

Stock Market Today

  • Live Cattle Futures Rally As USDA Reports Steady Slaughter and Strong Auction Prices
    June 10, 2026, 5:26 AM EDT. Live cattle futures rebounded Tuesday with gains of $1.50 to $2.97 across contracts, led by August 2025 delivery. Feeder cattle futures jumped $2.00 to $3.45, supported by a $5.63 increase in the CME Feeder Cattle Index to 367.01. The weekly Oklahoma City feeder cattle auction saw steady to higher prices, with feeder steers up as much as $10 and heifers rising $2-$8. USDA-reported fed cattle slaughter totaled 109,000 head Tuesday, down week-over-week and year-over-year. Boxed beef prices mixed, with Choice boxes rising 70 cents and Select falling $1.16. The USDA pasture rating improved slightly. Market activity suggests resilience amid tight supplies and solid demand, bolstering cattle futures.

Latest articles

Ondas Stock Comes Back Into the Spotlight After 13% Drop; Drone Trade Faces Fresh Challenge

Ondas Dips Premarket After 2.7 Million-Share Filing

10 June 2026
SoFi Technologies traded near $16.47 in early premarket, little changed as investors weighed its AI and digital asset product push against a risk-off market mood, with no fresh earnings news and inflation data looming that could impact rates, loan demand, and fintech valuations.

SoFi Stock Faces a Crucial Pre-Market Test as Wall Street Turns Defensive

10 June 2026
Rolls-Royce shares rebounded 1.5% in London after Tuesday’s 2.68% drop, as investors weighed fresh airline criticism over engine delays against the company’s reaffirmed 2026 profit and cash flow guidance; CEO Tufan Erginbilgic said Rolls had a “strong start to the year,” but risks remain if airline pressure leads to higher costs or slower cash conversion.
LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

10 June 2026
LVMH shares slipped 0.49% to €489.90 in Paris after a four-day rebound, as investors weighed RBC’s reiterated Buy rating with a €600 target against ongoing 2026 losses and a 24% year-to-date drop; all eyes now turn to July’s first-half results for signs of recovery in Fashion & Leather Goods and any relief from Middle East weakness.
Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

10 June 2026
Roche’s participation certificates climbed 1.07% to CHF 322.20 after announcing a $2.3 billion deal with Nurix Therapeutics for late-stage blood-cancer drug bexobrutideg, planned to enter Phase 3 trials this summer in CLL, as investors weigh the asset’s potential to offset losses from expiring patents and drive mid-single-digit sales growth in 2026.
YY Group Shares Jump Premarket on Humanoid Robot Move

YY Group Shares Jump Premarket on Humanoid Robot Move

10 June 2026
YYGH jumped to $0.19 in early pre-market after announcing deployment of Unitree G1 humanoid robots for facility management, aiming to turn operational know-how into higher-margin data assets, but the stock remains volatile near record lows after a recent reverse split and has not confirmed robot-driven revenue or margin gains.
Go toTop